AU2002357817A1 - Klcs as modifiers of the p53 pathway and methods of use - Google Patents

Klcs as modifiers of the p53 pathway and methods of use

Info

Publication number
AU2002357817A1
AU2002357817A1 AU2002357817A AU2002357817A AU2002357817A1 AU 2002357817 A1 AU2002357817 A1 AU 2002357817A1 AU 2002357817 A AU2002357817 A AU 2002357817A AU 2002357817 A AU2002357817 A AU 2002357817A AU 2002357817 A1 AU2002357817 A1 AU 2002357817A1
Authority
AU
Australia
Prior art keywords
klcs
modifiers
pathway
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002357817A
Other versions
AU2002357817A8 (en
Inventor
Michael A. Costa
Tak Hung
Mark Lackner
Mark E. Maxwell
Diane Parry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Exelixis Inc
Original Assignee
Exelixis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exelixis Inc filed Critical Exelixis Inc
Publication of AU2002357817A1 publication Critical patent/AU2002357817A1/en
Publication of AU2002357817A8 publication Critical patent/AU2002357817A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2002357817A 2001-12-13 2002-12-12 Klcs as modifiers of the p53 pathway and methods of use Abandoned AU2002357817A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34032301P 2001-12-13 2001-12-13
US60/340,323 2001-12-13
PCT/US2002/039633 WO2003052066A2 (en) 2001-12-13 2002-12-12 Klcs as modifiers of the p53 pathway and methods of use

Publications (2)

Publication Number Publication Date
AU2002357817A1 true AU2002357817A1 (en) 2003-06-30
AU2002357817A8 AU2002357817A8 (en) 2003-06-30

Family

ID=23332856

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002357817A Abandoned AU2002357817A1 (en) 2001-12-13 2002-12-12 Klcs as modifiers of the p53 pathway and methods of use

Country Status (2)

Country Link
AU (1) AU2002357817A1 (en)
WO (1) WO2003052066A2 (en)

Also Published As

Publication number Publication date
WO2003052066A3 (en) 2004-01-15
AU2002357817A8 (en) 2003-06-30
WO2003052066A2 (en) 2003-06-26

Similar Documents

Publication Publication Date Title
AU2002310256A1 (en) Ppp2cs as modifiers of the p53 pathway and methods of use
AU2003224638A1 (en) PDPK1s AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
EP1421384A4 (en) Hprp4s as modifiers of the p53 pathway and methods of use
AU2002352903A1 (en) Mesoporous materials and methods
AU2002314466A1 (en) Withasol and methods of use
AU2002314887A1 (en) Gads as modifiers of the p53 pathway and methods of use
AU2002239933A1 (en) Antineoplastic polyalkoxyalkylsiloxanes and methods of use thereof
AU2002337916A1 (en) Modifier of the p53 pathway and methods of use
AU2003248879A1 (en) RABS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
AU2003295881A1 (en) Lamps as modifiers of the p53 pathway and methods of use
AU2003303094A1 (en) MAT2As AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
AU2002357817A1 (en) Klcs as modifiers of the p53 pathway and methods of use
AU2002345486A1 (en) Slc13as as modifiers of the p53 pathway and methods of use
AU2002312283A1 (en) Srpks as modifiers of the p53 pathway and methods of use
AU2002303951A1 (en) Glras as modifiers of the p53 pathway and methods of use
AU2002303947A1 (en) Pecis as modifiers of the p53 pathway and methods of use
AU2002314874A1 (en) Modifiers of the p53 pathway and methods of use
AU2002332130A1 (en) Msrebps as modifiers of the srebp pathway and methods of use
AU2002361654A1 (en) Mbcats as modifiers of the beta-catenin pathway and methods of use
AU2003274911A1 (en) Mrbs as modifiers of the rb pathway and methods of use
AU2002337915A1 (en) Ctsls as modifiers of the p53 and apaf-1 pathways and methods of use
AU2003248876A1 (en) MP53S AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
AU2003278811A1 (en) LDLRs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
AU2003263993A1 (en) MP2153S AS MODIFIERS OF THE p21 OR p53 PATHWAY AND METHODS OF USE
AU2002354668A1 (en) Modifiers of the p21 pathway and methods of use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase